BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21102234)

  • 1. Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.
    Govindan R
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S433. PubMed ID: 21102234
    [No Abstract]   [Full Text] [Related]  

  • 2. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
    Somaiah N; Simon NG; Simon GR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
    Somaiah N; Simon GR
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecularly targeted therapies in locally advanced non-small-cell lung cancer.
    Devarakonda S; Morgensztern D; Govindan R
    Clin Lung Cancer; 2013 Sep; 14(5):467-72. PubMed ID: 23684057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances of medical treatment in advanced non-small cell lung cancer in 2011 American Society of Clinical Oncology Annual Meeting].
    Xu X; Wang J
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):943-8. PubMed ID: 22152695
    [No Abstract]   [Full Text] [Related]  

  • 6. [The update of emerging targeted therapies of lung cancer].
    Shang CC; Zhang L
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):447-449. PubMed ID: 28592047
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging gene mutation targets in lung cancer.
    Johnson BE
    Clin Adv Hematol Oncol; 2015 Dec; 13(12):812-4. PubMed ID: 27058846
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary of presentation from the targeted therapy in lung cancer meeting.
    Govindan R
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1757. PubMed ID: 22005528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MEK for the treatment of non-small-cell lung cancer.
    Goldman JW; Garon EB
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S377-8. PubMed ID: 23160324
    [No Abstract]   [Full Text] [Related]  

  • 10. Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?
    Keller JA; Erson-Bensan AE; Petty EM
    Cancer Biol Ther; 2010 Nov; 10(9):942-4. PubMed ID: 21057211
    [No Abstract]   [Full Text] [Related]  

  • 11. Hsp90 inhibitors.
    Pillai RN; Ramalingam SS
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S407-8. PubMed ID: 23160336
    [No Abstract]   [Full Text] [Related]  

  • 12. How should we manage non-small-cell lung cancer "not-otherwise-specified"?
    Kim YH; Nishimura Y; Funada Y
    Med Oncol; 2021 Jun; 38(7):82. PubMed ID: 34117925
    [No Abstract]   [Full Text] [Related]  

  • 13. MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma.
    Pradhan R; Singhvi G; Dubey SK; Gupta G; Dua K
    Future Med Chem; 2019 Apr; 11(8):793-795. PubMed ID: 30994024
    [No Abstract]   [Full Text] [Related]  

  • 14. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
    Zarogoulidis P; Yarmus L; Zarogoulidis K
    Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphatidylinositol-3-kinase pathway.
    Reckamp KL
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
    Massarelli E; Papadimitrakopoulou VA
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
    [No Abstract]   [Full Text] [Related]  

  • 18. The new drugs and biologics as sensitizers in the treatment of non-small cell lung cancer.
    Turrisi AT
    Suppl Tumori; 2002; 1(4):S55-7. PubMed ID: 12415822
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on HER1-3 in advanced non-small-cell lung cancer.
    Horn L; Lovly C
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].
    Italiano A; Besse B; Planchard D; Soria JC
    Bull Cancer; 2007; 94(7 Suppl):F177-88. PubMed ID: 17964994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.